- Expression and prognostic significance of programmed death-ligand 1 (PD-L1) in Merkel cell carcinoma2019 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- A noninterventional, multinational study to assess PD-L1 expression in cytological and histological lung cancer specimens2020 | Publication without faculty affiliation
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Immunotherapy of triple negative breast cancer2019 | First Faculty of Medicine, Faculty of Physical Education and Sport, Central Library of Charles University
- The current standard of NSCLC pathological examination in the Czech Republic2022 | Faculty of Medicine in Hradec Králové
- Atypical response to anti-PD-1 therapy followed by long-term survival in non-small cell lung cancer - case reports2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Current procedures and news in the treatment of lung cancer2021 | First Faculty of Medicine
- Predictive markers in breast cancer2021 | First Faculty of Medicine
- The PD-L1-Associated Carcinogenesis May Encompass Oncogenes UHRF2 and PTPRDPublication without faculty affiliation
- Neopterin as a biomarker of immune response in cancer patients2017 | Faculty of Medicine in Hradec Králové, Faculty of Pharmacy in Hradec Králové
- Laboratory Parameters Associated with Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer2022 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- The prognostic effect of neoadjuvant chemoradiotherapy on the change of PD-L1 expression in patients with locally advanced rectal adenocarcinoma2017 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature2020 | First Faculty of Medicine, Third Faculty of Medicine
- PD-L1 immunohistochemistry in non-small-cell lung cancer: unraveling differences in staining concordance and interpretation2021 | Faculty of Medicine in Hradec Králové
- Loss of SATB2 expression correlates with cytokeratin 7 and PD-L1 tumor cell positivity and aggressiveness in colorectal cancer2022 | First Faculty of Medicine, Third Faculty of Medicine
- High tumour mutational burden is associated with strong PD-L1 expression, HPV negativity, and worse survival in penile squamous cell carcinoma: an analysis of 165 cases2023 | First Faculty of Medicine, Third Faculty of Medicine
- PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma2022 | First Faculty of Medicine, Faculty of Science
- First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer2017 | Central Library of Charles University
- Endobronchial ultrasound in diagnosing and staging of lung cancer by Acquire 22G TBNB versus regular 22G TBNA needles: A randomized clinical trial2023 | Publication without faculty affiliation
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial2019 | Second Faculty of Medicine